{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:51:40Z","timestamp":1795020700734,"version":"4.10.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:00:00Z","timestamp":1539561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:00:00Z","timestamp":1539561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P22072"],"award-info":[{"award-number":["P22072"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P26603"],"award-info":[{"award-number":["P26603"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P22072"],"award-info":[{"award-number":["P22072"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Cluster \u201cTranslational Cancer Therapy Research\u201d Vienna"},{"name":"Sonja Hager is a recipient of the DOC Fellowship from the Austrian Academy of Sciences."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Due to their high biological activity, thiosemicarbazones have been developed for treatment of diverse diseases, including cancer, resulting in multiple clinical trials especially of the lead compound Triapine. During the last years, a novel subclass of anticancer thiosemicarbazones has attracted substantial interest based on their enhanced cytotoxic activity. Increasing evidence suggests that the double-dimethylated Triapine derivative Me<jats:sub>2<\/jats:sub>NNMe<jats:sub>2<\/jats:sub> differs from Triapine not only in its efficacy but also in its mode of action. Here we show that Me<jats:sub>2<\/jats:sub>NNMe<jats:sub>2<\/jats:sub>- (but not Triapine)-treated cancer cells exhibit all hallmarks of paraptotic cell death including, besides the appearance of endoplasmic reticulum (ER)-derived vesicles, also mitochondrial swelling and caspase-independent cell death via the MAPK signaling pathway. Subsequently, we uncover that the copper complex of Me<jats:sub>2<\/jats:sub>NNMe<jats:sub>2<\/jats:sub> (a supposed intracellular metabolite) inhibits the ER-resident protein disulfide isomerase, resulting in a specific form of ER stress based on disruption of the Ca<jats:sup>2+<\/jats:sup> and ER thiol\u00a0redox\u00a0homeostasis. Our findings indicate that compounds like Me<jats:sub>2<\/jats:sub>NNMe<jats:sub>2<\/jats:sub> are of interest especially for the treatment of apoptosis-resistant cancer and provide new insights into mechanisms underlying drug-induced paraptosis.<\/jats:p>","DOI":"10.1038\/s41419-018-1102-z","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T09:06:00Z","timestamp":1539594360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["The thiosemicarbazone Me2NNMe2 induces paraptosis by disrupting the ER thiol redox homeostasis based on protein disulfide isomerase inhibition"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8221-1044","authenticated-orcid":false,"given":"Sonja","family":"Hager","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Korbula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Bielec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5486-9340","authenticated-orcid":false,"given":"Michael","family":"Grusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Pirker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2025-0739","authenticated-orcid":false,"given":"Markus","family":"Schosserer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Liendl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Grillari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Nowikovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6589-6950","authenticated-orcid":false,"given":"Veronika F. S.","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergely","family":"Szak\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard K.","family":"Keppler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0014-1658","authenticated-orcid":false,"given":"Walter","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian R.","family":"Kowol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Heffeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,15]]},"reference":[{"key":"1102_CR1","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.4155\/fmc.09.80","volume":"1","author":"DS Kalinowski","year":"2009","unstructured":"Kalinowski, D. S., Quach, P. & Richardson, D. R. Thiosemicarbazones: the new wave in cancer treatment. Future Med. Chem. 1, 1143\u20131151 (2009).","journal-title":"Future Med. Chem."},{"key":"1102_CR2","doi-asserted-by":"publisher","unstructured":"Heffeter, P. et al. Anticancer thiosemicarbazones: chemical properties, interaction with iron metabolism, and resistance development. Antioxid. Redox Signal. https:\/\/doi.org\/10.1089\/ars.2017.7487 (2018).","DOI":"10.1089\/ars.2017.7487"},{"key":"1102_CR3","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/S0145-2126(03)00118-8","volume":"27","author":"FJ Giles","year":"2003","unstructured":"Giles, F. J. et al. Phase I and pharmacodynamic study of Triapine, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia. Leuk. Res. 27, 1077\u20131083 (2003).","journal-title":"Leuk. Res."},{"key":"1102_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.leukres.2007.05.003","volume":"32","author":"JE Karp","year":"2008","unstructured":"Karp, J. E. et al. A phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disorders. Leuk. Res. 32, 71\u201377 (2008).","journal-title":"Leuk. Res."},{"key":"1102_CR5","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.leukres.2005.12.013","volume":"30","author":"KW Yee","year":"2006","unstructured":"Yee, K. W. et al. Triapine and cytarabine is an active combination in patients with acute leukemia or myelodysplastic syndrome. Leuk. Res. 30, 813\u2013822 (2006).","journal-title":"Leuk. Res."},{"key":"1102_CR6","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3324\/haematol.2013.097246","volume":"99","author":"JF Zeidner","year":"2014","unstructured":"Zeidner, J. F. et al. A phase II trial of sequential ribonucleotide reductase inhibition in aggressive myeloproliferative neoplasms. Haematologica 99, 672\u2013678 (2014).","journal-title":"Haematologica"},{"key":"1102_CR7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10637-008-9123-6","volume":"26","author":"S Attia","year":"2008","unstructured":"Attia, S. et al. A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas. Invest. New Drugs 26, 369\u2013379 (2008).","journal-title":"Invest. New Drugs"},{"key":"1102_CR8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10637-007-9044-9","volume":"25","author":"JJ Knox","year":"2007","unstructured":"Knox, J. J. et al. Phase II study of Triapine in patients with metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC IND.161). Invest. New Drugs 25, 471\u2013477 (2007).","journal-title":"Invest. New Drugs"},{"key":"1102_CR9","doi-asserted-by":"publisher","first-page":"5759","DOI":"10.1021\/jm100561b","volume":"53","author":"PJ Jansson","year":"2010","unstructured":"Jansson, P. J., Sharpe, P. C., Bernhardt, P. V. & Richardson, D. R. Novel thiosemicarbazones of the ApT and DpT series and their copper complexes: identification of pronounced redox activity and characterization of their antitumor activity. J. Med. Chem. 53, 5759\u20135769 (2010).","journal-title":"J. Med. Chem."},{"key":"1102_CR10","doi-asserted-by":"publisher","first-page":"e0191766","DOI":"10.1371\/journal.pone.0191766","volume":"13","author":"S Maleki Vareki","year":"2018","unstructured":"Maleki Vareki, S., Salim, K. Y., Danter, W. R. & Koropatnick, J. Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines. PLoS ONE 13, e0191766 (2018).","journal-title":"PLoS ONE"},{"key":"1102_CR11","doi-asserted-by":"publisher","first-page":"6739","DOI":"10.1021\/acs.jmedchem.6b00342","volume":"59","author":"CR Kowol","year":"2016","unstructured":"Kowol, C. R. et al. Impact of stepwise NH2-methylation of triapine on the physicochemical properties, anticancer activity, and resistance circumvention. J. Med. Chem. 59, 6739\u20136752 (2016).","journal-title":"J. Med. Chem."},{"key":"1102_CR12","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.bcp.2014.08.006","volume":"91","author":"K Ishiguro","year":"2014","unstructured":"Ishiguro, K. et al. Distinct mechanisms of cell-kill by triapine and its terminally dimethylated derivative Dp44mT due to a loss or gain of activity of their copper(II) complexes. Biochem. Pharmacol. 91, 312\u2013322 (2014).","journal-title":"Biochem. Pharmacol."},{"key":"1102_CR13","doi-asserted-by":"publisher","first-page":"5871","DOI":"10.1158\/0008-5472.CAN-11-1218","volume":"71","author":"DB Lovejoy","year":"2011","unstructured":"Lovejoy, D. B. et al. Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes. Cancer Res. 71, 5871\u20135880 (2011).","journal-title":"Cancer Res."},{"key":"1102_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.381","volume":"7","author":"NA Seebacher","year":"2016","unstructured":"Seebacher, N. A., Richardson, D. R. & Jansson, P. J. A mechanism for overcoming P-glycoprotein-mediated drug resistance: novel combination therapy that releases stored doxorubicin from lysosomes via lysosomal permeabilization using Dp44mT or DpC. Cell Death Dis. 7, e2510 (2016).","journal-title":"Cell Death Dis."},{"key":"1102_CR15","doi-asserted-by":"publisher","first-page":"14376","DOI":"10.1073\/pnas.97.26.14376","volume":"97","author":"S Sperandio","year":"2000","unstructured":"Sperandio, S., de Belle, I. & Bredesen, D. E. An alternative, nonapoptotic form of programmed cell death. Proc. Natl Acad. Sci. USA 97, 14376\u201314381 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1102_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.pharmthera.2016.01.003","volume":"162","author":"D Lee","year":"2016","unstructured":"Lee, D., Kim, I. Y., Saha, S. & Choi, K. S. Paraptosis in the anti-cancer arsenal of natural products. Pharmacol. Ther. 162, 120\u2013133 (2016).","journal-title":"Pharmacol. Ther."},{"key":"1102_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13698-1","volume":"7","author":"V Gandin","year":"2017","unstructured":"Gandin, V. et al. Therapeutic potential of the phosphino Cu(I) complex (HydroCuP) in the treatment of solid tumors. Sci. Rep. 7, 13936 (2017).","journal-title":"Sci. Rep."},{"key":"1102_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ejphar.2017.09.003","volume":"815","author":"X Chen","year":"2017","unstructured":"Chen, X. et al. Hinokitiol copper complex inhibits proteasomal deubiquitination and induces paraptosis-like cell death in human cancer cells. Eur. J. Pharmacol. 815, 147\u2013155 (2017).","journal-title":"Eur. J. Pharmacol."},{"key":"1102_CR19","doi-asserted-by":"publisher","first-page":"24306","DOI":"10.1074\/jbc.M109.026583","volume":"284","author":"S Tardito","year":"2009","unstructured":"Tardito, S. et al. The thioxotriazole copper(II) complex A0 induces endoplasmic reticulum stress and paraptotic death in human cancer cells. J. Biol. Chem. 284, 24306\u201324319 (2009).","journal-title":"J. Biol. Chem."},{"key":"1102_CR20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1080\/05704920701551530","volume":"42","author":"Z Movasaghi","year":"2007","unstructured":"Movasaghi, Z., Rehman, S. & Rehman, I. U. Raman spectroscopy of biological tissues. Appl. Spectrosc. Rev. 42, 493\u2013541 (2007).","journal-title":"Appl. Spectrosc. Rev."},{"key":"1102_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cbi.2018.02.003","volume":"283","author":"J Xue","year":"2018","unstructured":"Xue, J. et al. Morusin induces paraptosis-like cell death through mitochondrial calcium overload and dysfunction in epithelial ovarian cancer. Chem. Biol. Interact. 283, 59\u201374 (2018).","journal-title":"Chem. Biol. Interact."},{"key":"1102_CR22","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.18632\/oncotarget.2256","volume":"5","author":"MJ Yoon","year":"2014","unstructured":"Yoon, M. J. et al. Release of Ca2+ from the endoplasmic reticulum and its subsequent influx into mitochondria trigger celastrol-induced paraptosis in cancer cells. Oncotarget 5, 6816\u20136831 (2014).","journal-title":"Oncotarget"},{"key":"1102_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.85","volume":"4","author":"M Bury","year":"2013","unstructured":"Bury, M. et al. Ophiobolin A induces paraptosis-like cell death in human glioblastoma cells by decreasing BKCa channel activity. Cell Death Dis. 4, e561 (2013).","journal-title":"Cell Death Dis."},{"key":"1102_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bbamcr.2011.11.020","volume":"1823","author":"HM Heath-Engel","year":"2012","unstructured":"Heath-Engel, H. M., Wang, B. & Shore, G. C. Bcl2 at the endoplasmic reticulum protects against a Bax\/Bak-independent paraptosis-like cell death pathway initiated via p20Bap31. Biochim. Biophys. Acta 1823, 335\u2013347 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"1102_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.85","volume":"5","author":"MJ Yoon","year":"2014","unstructured":"Yoon, M. J. et al. Stronger proteasomal inhibition and higher CHOP induction are responsible for more effective induction of paraptosis by dimethoxycurcumin than curcumin. Cell Death Dis. 5, e1112 (2014).","journal-title":"Cell Death Dis."},{"issue":"20","key":"1102_CR26","doi-asserted-by":"publisher","first-page":"6942","DOI":"10.1039\/C8DT00783G","volume":"47","author":"Liang He","year":"2018","unstructured":"He, L. et al. Cyclometalated iridium(iii) complexes induce mitochondria-derived paraptotic cell death and inhibit tumor growth in vivo. Dalton Trans. https:\/\/doi.org\/10.1039\/c8dt00783g (2018).","journal-title":"Dalton Transactions"},{"key":"1102_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.tiv.2018.04.014","volume":"51","author":"Monika Garrido-Armas","year":"2018","unstructured":"Garrido-Armas, M. et al. Paraptosis in human glioblastoma cell line induced by curcumin. Toxicol. In Vitro https:\/\/doi.org\/10.1016\/j.tiv.2018.04.014 (2018).","journal-title":"Toxicology in Vitro"},{"key":"1102_CR28","doi-asserted-by":"crossref","first-page":"106740","DOI":"10.18632\/oncotarget.22537","volume":"8","author":"IY Kim","year":"2017","unstructured":"Kim, I. Y. et al. Ophiobolin A kills human glioblastoma cells by inducing endoplasmic reticulum stress via disruption of thiol proteostasis. Oncotarget 8, 106740\u2013106752 (2017).","journal-title":"Oncotarget"},{"key":"1102_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.yexcr.2018.02.018","volume":"364","author":"D Nedungadi","year":"2018","unstructured":"Nedungadi, D. et al. 6-Shogaol induces caspase-independent paraptosis in cancer cells via proteasomal inhibition. Exp. Cell Res. 364, 243\u2013251 (2018).","journal-title":"Exp. Cell Res."},{"key":"1102_CR30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.bbrc.2003.09.226","volume":"311","author":"S Narindrasorasak","year":"2003","unstructured":"Narindrasorasak, S., Yao, P. & Sarkar, B. Protein disulfide isomerase, a multifunctional protein chaperone, shows copper-binding activity. Biochem. Biophys. Res. Commun. 311, 405\u2013414 (2003).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1102_CR31","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1016\/j.freeradbiomed.2012.02.037","volume":"52","author":"FR Laurindo","year":"2012","unstructured":"Laurindo, F. R., Pescatore, L. A. & Fernandes Dde, C. Protein disulfide isomerase in redox cell signaling and homeostasis. Free Radic. Biol. Med. 52, 1954\u20131969 (2012).","journal-title":"Free Radic. Biol. Med."},{"key":"1102_CR32","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3390\/cancers6031769","volume":"6","author":"G Housman","year":"2014","unstructured":"Housman, G. et al. Drug resistance in cancer: an overview. Cancers 6, 1769\u20131792 (2014).","journal-title":"Cancers"},{"key":"1102_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.217","volume":"8","author":"L Wang","year":"2017","unstructured":"Wang, L., Gundelach, J. H. & Bram, R. J. Cycloheximide promotes paraptosis induced by inhibition of cyclophilins in glioblastoma multiforme. Cell Death Dis. 8, e2807 (2017).","journal-title":"Cell Death Dis."},{"key":"1102_CR34","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1083\/jcb.200904060","volume":"186","author":"G Li","year":"2009","unstructured":"Li, G. et al. Role of ERO1-alpha-mediated stimulation of inositol 1,4,5-triphosphate receptor activity in endoplasmic reticulum stress-induced apoptosis. J. Cell Biol. 186, 783\u2013792 (2009).","journal-title":"J. Cell Biol."},{"key":"1102_CR35","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.bbamcr.2016.01.026","volume":"1863","author":"DS Kalinowski","year":"2016","unstructured":"Kalinowski, D. S. et al. Redox cycling metals: pedaling their roles in metabolism and their use in the development of novel therapeutics. Biochim. Biophys. Acta 1863, 727\u2013748 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"1102_CR36","first-page":"166","volume":"1845","author":"DJ Lane","year":"2014","unstructured":"Lane, D. J. et al. Expanding horizons in iron chelation and the treatment of cancer: role of iron in the regulation of ER stress and the epithelial-mesenchymal transition. Biochim. Biophys. Acta 1845, 166\u2013181 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"1102_CR37","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0065-2571(01)00028-0","volume":"42","author":"TR Crenshaw","year":"2002","unstructured":"Crenshaw, T. R. & Cory, J. G. Overexpression of protein disulfide isomerase-like protein in a mouse leukemia L1210 cell line selected for resistance to 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone, a ribonucleotide reductase inhibitor. Adv. Enzym. Regul. 42, 143\u2013157 (2002).","journal-title":"Adv. Enzym. Regul."},{"key":"1102_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.369","volume":"8","author":"P Kranz","year":"2017","unstructured":"Kranz, P. et al. PDI is an essential redox-sensitive activator of PERK during the unfolded protein response (UPR). Cell Death Dis. 8, e2986 (2017).","journal-title":"Cell Death Dis."},{"key":"1102_CR39","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.bbamcr.2014.01.009","volume":"1843","author":"NJ Darling","year":"2014","unstructured":"Darling, N. J. & Cook, S. J. The role of MAPK signalling pathways in the response to endoplasmic reticulum stress. Biochim. Biophys. Acta 1843, 2150\u20132163 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"1102_CR40","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/abbs\/gmu048","volume":"46","author":"Y Li","year":"2014","unstructured":"Li, Y., Guo, Y., Tang, J., Jiang, J. & Chen, Z. New insights into the roles of CHOP-induced apoptosis in ERstress. Acta Biochim. Biophys. Sin. 46, 629\u2013640 (2014).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"1102_CR41","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1101\/gad.1250704","volume":"18","author":"SJ Marciniak","year":"2004","unstructured":"Marciniak, S. J. et al. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev. 18, 3066\u20133077 (2004).","journal-title":"Genes Dev."},{"key":"1102_CR42","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.1093\/nar\/28.24.4987","volume":"28","author":"M Ubeda","year":"2000","unstructured":"Ubeda, M. & Habener, J. F. CHOP gene expression in response to endoplasmic-reticular stress requires NFY interaction with different domains of a conserved DNA-binding element. Nucleic Acids Res. 28, 4987\u20134997 (2000).","journal-title":"Nucleic Acids Res."},{"key":"1102_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.192","volume":"4","author":"PK Singha","year":"2013","unstructured":"Singha, P. K., Pandeswara, S., Venkatachalam, M. A. & Saikumar, P. Manumycin A inhibits triple-negative breast cancer growth through LC3-mediated cytoplasmic vacuolation death. Cell Death Dis. 4, e457 (2013).","journal-title":"Cell Death Dis."},{"key":"1102_CR44","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3389\/fncel.2014.00147","volume":"8","author":"V Tadic","year":"2014","unstructured":"Tadic, V., Prell, T., Lautenschlaeger, J. & Grosskreutz, J. The ER mitochondria calcium cycle and ER stress response as therapeutic targets in amyotrophic lateral sclerosis. Front. Cell. Neurosci. 8, 147 (2014).","journal-title":"Front. Cell. Neurosci."},{"key":"1102_CR45","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3390\/ijms14010434","volume":"14","author":"B Bhandary","year":"2012","unstructured":"Bhandary, B., Marahatta, A., Kim, H. R. & Chae, H. J. An involvement of oxidative stress in endoplasmic reticulum stress and its associated diseases. Int. J. Mol. Sci. 14, 434\u2013456 (2012).","journal-title":"Int. J. Mol. Sci."},{"key":"1102_CR46","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1152\/jn.90534.2008","volume":"100","author":"K Hacker","year":"2008","unstructured":"Hacker, K. & Medler, K. F. Mitochondrial calcium buffering contributes to the maintenance of Basal calcium levels in mouse taste cells. J. Neurophysiol. 100, 2177\u20132191 (2008).","journal-title":"J. Neurophysiol."},{"key":"1102_CR47","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1126\/science.1081208","volume":"300","author":"L Scorrano","year":"2003","unstructured":"Scorrano, L. et al. BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science 300, 135\u2013139 (2003).","journal-title":"Science"},{"key":"1102_CR48","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/nchembio.467","volume":"6","author":"BG Hoffstrom","year":"2010","unstructured":"Hoffstrom, B. G. et al. Inhibitors of protein disulfide isomerase suppress apoptosis induced by misfolded proteins. Nat. Chem. Biol. 6, 900\u2013906 (2010).","journal-title":"Nat. Chem. Biol."},{"key":"1102_CR49","doi-asserted-by":"publisher","first-page":"5032","DOI":"10.1021\/jm900528d","volume":"52","author":"CR Kowol","year":"2009","unstructured":"Kowol, C. R. et al. Impact of metal coordination on cytotoxicity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine) and novel insights into terminal dimethylation. J. Med. Chem. 52, 5032\u20135043 (2009).","journal-title":"J. Med. Chem."},{"key":"1102_CR50","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1124\/jpet.104.073395","volume":"312","author":"P Heffeter","year":"2005","unstructured":"Heffeter, P. et al. Intrinsic and acquired forms of resistance against the anticancer ruthenium compound KP1019 [indazolium trans-[tetrachlorobis(1H-indazole)ruthenate (III)] (FFC14A). J. Pharmacol. Exp. Ther. 312, 281\u2013289 (2005).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1102_CR51","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/bjc.2016.449","volume":"116","author":"B Englinger","year":"2017","unstructured":"Englinger, B. et al. Loss of CUL4A expression is underlying cisplatin hypersensitivity in colorectal carcinoma cells with acquired trabectedin resistance. Br. J. Cancer 116, 489\u2013500 (2017).","journal-title":"Br. J. Cancer"},{"key":"1102_CR52","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1124\/mol.113.090605","volume":"85","author":"R Trondl","year":"2014","unstructured":"Trondl, R. et al. Triapine and a more potent dimethyl derivative induce endoplasmic reticulum stress in cancer cells. Mol. Pharmacol. 85, 451\u2013459 (2014).","journal-title":"Mol. Pharmacol."},{"key":"1102_CR53","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/path.4567","volume":"237","author":"V Laszlo","year":"2015","unstructured":"Laszlo, V. et al. Epigenetic down-regulation of integrin alpha7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma. J. Pathol. 237, 203\u2013214 (2015).","journal-title":"J. Pathol."},{"key":"1102_CR54","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"1102_CR55","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/bioinformatics\/btt285","volume":"29","author":"W Luo","year":"2013","unstructured":"Luo, W. & Brouwer, C. Pathview: an R\/Bioconductor package for pathway-based data integration and visualization. Bioinformatics 29, 1830\u20131831 (2013).","journal-title":"Bioinformatics"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1102-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1102-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1102-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:24:18Z","timestamp":1671539058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1102-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,15]]},"references-count":55,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11]]}},"alternative-id":["1102"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-1102-z","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,15]]},"assertion":[{"value":"13 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1052"}}